Stuart Aronson
Analyst · Ladenburg
Thank you, John. Good afternoon and thank you for joining us today. I hope you and your families continue to be safe and healthy as we navigate these unprecedented times. As you are aware, we issued our press release this morning prior to market open. I hope you have had a chance to review our results, which are also available on our website. I'm going to start by addressing our results relative to market conditions. Joyson will then discuss your performance in more detail, after which we will open the line for questions. We are pleased to report the second quarter results demonstrated a strong rebound from the lows experience in mid March. First, I would like to share that NAV increased materially to 14.61 per share, compared to 13.86 per share in Q1. This 5.4% increase resulted from several factors: increased marks on assets, resulting from price improvements on the market, credit improvements on COVID-19 impacted loans, our work with our borrowers and sponsors and an opportunistic secondary market purchase. Second, we have dramatically improved liquidity in the BDC with approximately $75 million of available capital under our secured credit line, excluding our $100 million accordion facility. This materially lowers downside risk relative to the prior quarter, should market volatility return, while providing the opportunity to take advantage of more attractive terms in the marketplace, which include lower leverage and higher prices on loans. During the quarter, there were no adjustment items to core NII, so we are reporting second quarter in GAAP net investment income of $5.2 million or $0.255 per share. This compares to first quarter GAAP NII as explained $1 million or $0.297 per share, and first quarter core NII of $5.5 million or $0.267 cents per share. The NII level this quarter resulted from a combination of lower asset balances, driven by repayments, interest rate declines, lower amendment and prepayment penalties compared to our historical trends and the income impact of assets that are on non-accrual. Despite our increase in NAV, we would have liked to have seen stronger net investment income, deal activity was needed for the greater part of Q2 and while the market exhibited high volatility, we focused on making sure the BDC was safe with maximum liquidity. In our investor presentation, we shared an estimate of the level of COVID-19 risk exposure across our portfolio. When we produce these reports, we take into account the most recent data on each company, including feedback from management about real-time performance and their best projections to what will occur going forward. We have had a strong portfolio of focus since COVID hit and speak to management teams of impacted borrowers as frequently as every week. As you can see in the presentation accounts which are classified as either very high or high exposure collectively represent approximately 7% of our portfolio, which we believe is manageable considering the extreme disruption across the economy. I’m pleased to share that across our portfolio, companies that were impacted by COVID-19 received consistent support from sponsors and private owners through equity injections and cost containment measures. We are working with owners of these companies to ensure that equity injections of liquidity are sufficient to bridge the companies into 2021. During the quarter we entered into three new positions and three add-ons totaling $39.4 million in gross deployments. Of our three new positions which totaled $33.6 million two were non-sponsor. All portfolio additions during the quarter were first lien and our weighted average effective yield on income producing investments for Q2 was 9.6% compared to 9.9% during Q1. Total repayments in sales were $36.6 million, including $24.8 million pay down on [CDA] (Ph), which was our largest and oldest active loan. This pay down meaningfully enhances our liquidity reduces second lien portfolio concentration and improves our credit quality. As I have shared we have made tremendous progress in improving our liquidity and outstanding borrowings. Our JPMorgan facility has a maximum borrowing limit of $250 million with an additional $100 million accordion feature and a minimum borrowing amount of $175 million. At the end of the first quarter we had outstanding balance of $231 million. At the end of the second quarter our outstanding balance decreased to $192 million. And as of today, our outstanding balance has reached the minimum borrowing amounts of $175 million. This influx of liquidity, when combined with our disciplined approach to sourcing will allow us to rebuild our pipeline and take advantage of the better deals now available in the marketplace. The deals we pursue will be to companies that are not distressed, have low COVID-19 and show low to moderate cyclicality risk as we believe there is a high risk of recession in 2021. At the end of the second quarter, the fair value of our portfolio decreased to $547.4 million compared to $557.1 million in Q1. Gross deployments of $39.4 million were fully offset by a transfer of $36.6 million in assets to our JV in addition to the $36.6 million of repayments in sales. However, we also recorded $17.8 million and mark-to-market gains during the quarter, which meaningfully improved NAV. During the quarter, we reached an agreement to restructure one of our credits in the fitness industry, which was an area we had identified in prior quarters as high risk while involved lenders will encounter a partial and hopefully temporary loss on their debt positions. The owner is injected material new equity into the company, and we were placing the restructured loan back on accrual in Q3. We received equity as a part of the restructuring, creating an opportunity for performance based upside over time as the COVID-19 issue is resolved. Second, as has been publicly disclosed, we restructured our debt position for our credit in the financial services space and have taken ownership of its operating subsidiary, pending regulatory approval. The loan has been marked at $0.80. As the investment it is expected to convert into new equity ownership after quarter end, we will have the possibility for upside based on the firm's future performance. And that firm is performing very, very well right now in the midst of program. Third, NAV benefited from improvements in the situation on our non-accrual account AG Kings, as you would expect one outcome from COVID-19 is stronger demand for groceries, which has been the case at AG Kings. And we also added to this position in a secondary trade temporarily affecting our reported non-accrual levels. We do have one small new account on non-accrual, which was marked down from $0.93 to $0.81. We are an active dialogue with the sponsor on this credit, as the borrower works to improve its current situation. In total, the non-accrual percentage of assets at WHF will be 3.3% after giving effect to the aforementioned restructured credit, going back on accrual, and excluding the effect of our secondary market purchase of Kings during the quarter. We have had ongoing success and improving portfolio diversification, and our portfolio had a fair value average debt investment size of $8.8 million. Within our debt portfolio 93.8% of our investments are now first lien, driven by the CDA repayment and 6.7% of our portfolio is sponsored backed. Leverage decreased to 0.86 times during the second quarter compared to 1.04 times at the end of Q1, as we focused on improving liquidity during the quarter. Having accomplished that goal, we are optimally positioned to deploy capital into high quality loans as market conditions are big on improving. Thus far in Q3, we have seven deals mandated as well as two potential add-ons, all of which are firstly in opportunities, and all of which will be priced at post COVID levels, and all of these deals are first lien. Unfunded commitments at quarter end were $2.4 million. In terms of the macro outlook during April and May, we saw very limited competition in our key markets, as pricing surged significantly, but deal activity was very muted as most M&A activity was canceled or delayed. Those trends reversed in June and July, is a number of competitors reentered the market. Pricing is now moderated to levels that are 75 to 150 basis points higher than pre-COVID, levels, and deal activity at least for us has recovered to about 80% to 90% of pre-COVID levels. In general, our opinion is that deals we are working on now are more attractive in terms of risk return to what we have seen since 2012 to 2013 advantages. Now many COVID impacted companies are raising money to enhance liquidity. But we have not participated in those distressed or stressed financings nor do we plan to. Our focus is financing opportunities for those companies that have low COVID impact and low to moderate cyclicality with the goal of keeping our portfolios stable and consistent as possible. Regarding portfolio performance, because the lower leverage and lower LTVs on average, our non-sponsored portfolio has performed better than our sponsored portfolio. As evidenced by the mark on the non-sponsored deals versus sponsored deals. All five of our highest COVID impacted loans are owned by PE firms, and thankfully all those PE owners have been supportive so far. In summary, while NII for the quarter was the below our goal, NAV has materially improved and liquidity is strong. Our goal is to carefully deploy capital on the improved market turns and position Whitehorse finance to be able to earn its dividends on a quarterly basis. I will now turn the call to Joyson for more detail on our financials.